Effects of Streptozotocin-induced Diabetes and Insulin on Phospholipid Content of R3230AC Mammary Tumor Cells

Julie Ann Ribes, Uma Narayanan, Russell Hilf

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The influence of diabetes and insulin treatment on the phospholipid content of R3230AC mammary tumors, a hormonally responsive neoplasm, was studied. Diabetes was induced by administration of streptozotocin 3 days prior to tumor implantation. Protamine zinc insulin, 3 lU/rat twice daily, was administered to tumor-bearing rats for 3 days. Enzymatically dissociated tumor cells from diabetic animals showed significant increases in phosphatidyl choline, lysophosphatidyl choline, phosphatidyl ethanol-amine, phosphatidyl serine, phosphatidyl inositol, and phosphatide acid, compared to controls. Diabetic animals treated with insulin displayed reductions in phosphatidyl choline, lysophosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and phosphatide acid to levels approximating those found in intact (control) animals. However, neither diabetes nor insulin treatment altered sphingomyelin levels. Mammary tumor cells from diabetic animals showed a 21% increase in DNA content compared to that in intact controls and treatment of diabetic animals with insulin lowered DNA level significantly. The responsiveness of both phospholipids and DNA content to changes in the insulin milieu of the host suggest that phospholipids may play an important role in mediating the effects of insulin on growth of R3230AC tumors.

Original languageEnglish
Pages (from-to)4833-4837
Number of pages5
JournalCancer Research
Volume45
Issue number10
StatePublished - Oct 1 1985

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Effects of Streptozotocin-induced Diabetes and Insulin on Phospholipid Content of R3230AC Mammary Tumor Cells'. Together they form a unique fingerprint.

Cite this